home / stock / seovf / seovf news

SEOVF News and Press, Sernova Corp From 09/07/23

Stock Information
Company Name: Sernova Corp
Stock Symbol: SEOVF
Market: OTC
Website: sernova.com
Menu
SEOVF SEOVF Quote SEOVF Short SEOVF News SEOVF Articles SEOVF Message Board
Get SEOVF Alerts

News, Short Squeeze, Breakout and More Instantly...
SEOVF - Sernova Provides Development Update on Proprietary Cellular Conformal Coating Technology in Combination with Cell Pouch Device

LONDON, Ontario and WINDHAM COUNTY, Conn., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today provided a development update on its exclusively licensed, proprietary conformal coating immune prot...
SEOVF - Sernova Corporation Announces the Appointment of Cynthia Pussinen as CEO

Industry veteran with deep commercial experience joins to lead the next stage of growth and development Dr. Philip Toleikis will serve as Chief Technology Officer Sernova to host investor calls LONDON, Ontario and WINDHAM COUNTY, Conn., Sept. 05, 2023 (GLOBE NEWSWIRE) --...

SEOVF - Sernova Expands Leadership Team with Appointment of Modestus Obochi, Ph.D., MBA, as Chief Business Officer

LONDON, Ontario, July 26, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a clinical-stage company and leader in cell therapeutics, today announced the appointment of Modestus Obochi, Ph.D., MBA, a veteran dealmaker and strategic leader with 25+ years of biotech...

SEOVF - Sernova Announces Positive Updated Interim Phase 1/2 Clinical Data for the Cell Pouch System(TM) at American Diabetes Association 83rd Scientific Sessions

In the first cohort of the ongoing Phase 1/2 clinical trial, the first 5 patients to complete protocol-defined islet transplants achieved insulin-independence for ongoing periods of 6 to 38 months. Following islet transplants to the 8-channel Cell Pouches, patients in the first cohort require...
SEOVF - Sernova to Present Updated Interim Phase 1/2 Clinical Data on Cell Pouch System(TM) During Oral Presentation at American Diabetes Association 83rd Scientific Sessions

LONDON, Ontario, June 22, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a clinical-stage company and leader in cell therapeutics, will be presenting updated interim data from its ongoing Phase 1/2 clinical trial of the Cell Pouch System™ in patients wit...

SEOVF - Sernova to Participate in Upcoming Truist Securities Cell Therapy Symposium

LONDON, Ontario, June 16, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced it will be participating in the upcoming symposia-cel Truist Securities Cell Therapy Symposium being held June 27, 20...

SEOVF - Sernova Announces Executive Alignment and Appoints New Board Chair

LONDON, Ontario, May 31, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a clinical-stage company and leader in cell therapeutics, today announced the outcomes from a strategic and executive leadership review conducted by its Board of Directors (the “Boar...
SEOVF - Sernova joins hands with AstraZeneca for potential therapeutic cell applications

2023-05-03 08:41:11 ET Clinical-stage company and leader in cell therapeutics, Sernova ( OTCQB:SEOVF ) entered into a preclinical research collaboration with AstraZeneca ( AZN ) to evaluate the use of Sernova’s Cell Pouch System in combination with AstraZeneca ...

SEOVF - Sernova Announces Research Collaboration with AstraZeneca to Evaluate Novel Potential Therapeutic Cell Applications

LONDON, Ontario, May 03, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced it has entered into a preclinical research collaboration with AstraZeneca (LSE/STO/Nasdaq:AZN) to evaluate the use of ...

SEOVF - Sernova Corp. Announces Voting Results of the 2023 Annual General Meeting of Shareholders

(TheNewswire) LONDON, Ontario – TheNewswire - April 2 8 , 2023 - Sernova Corp. (“ Sernova ” or the “ Corporation ”) (TSX:SVA) (OTC:SEOVF) (FSE/XETRA:PSH), a clinical-stage regenerative medicine company and le...
Previous 10 Next 10